REVOLADE 25MG TAB

REVOLADE 25MG is an eltrombopag-based tablet used to treat low platelet counts in patients with chronic immune thrombocytopenia (ITP). This medication works by stimulating platelet production in the bone marrow, helping to increase platelet levels and reduce bleeding risk. Each tablet contains 25mg of eltrombopag, the active pharmaceutical ingredient. REVOLADE is prescribed for adult patients who have not responded adequately to other treatments or cannot tolerate alternative therapies. Take this medication exactly as directed by your healthcare provider. Dosage is individualized based on platelet count response and tolerance. Regular blood tests are required to monitor platelet levels and liver function during treatment. Common side effects may include nausea, headache, and abdominal pain. Inform your doctor of any existing liver disease, heart conditions, or other medications before starting treatment. Store at room temperature away from moisture and heat. Keep out of reach of children. This is a prescription medication — consult your physician before use.